Associated Papers
Z-flipon variants reveal the many roles of Z-DNA and Z-RNA in health and disease.
Umerenkov D et al.
Life Science Alliance, 2023
37164635 (PubMed )
Supplement: LSA-2023-01962_TableS6.xlsx › Predicted_OMIM
Channelopathy Genes in Pulmonary Arterial Hypertension.
Welch CL et al.
Biomolecules, 2022
Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension.
Le Ribeuz H et al.
Biomolecules, 2020
TASK channels: channelopathies, trafficking, and receptor-mediated inhibition.
Inoue M et al.
Pflugers Archiv : European Journal of Physiology, 2020
A lower X-gate in TASK channels traps inhibitors within the vestibule.
Rödström KEJ et al.
Nature, 2020
Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension.
Abbasi Y et al.
Molecular Genetics & Genomic Medicine, 2018
TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications.
Olschewski A et al.
The European Respiratory Journal, 2017
Characterization of Disease-Associated Mutations in Human Transmembrane Proteins.
Molnár J et al.
Plos One, 2016
26986070 (PubMed )
Supplement: pone.0151760.s001.xlsx › disease
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.
Machado RD et al.
Human Mutation, 2015
Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.
Chokshi RH et al.
Molecular Pharmacology, 2015
Genetics of pulmonary hypertension.
Best DH et al.
Current Opinion in Cardiology, 2014
The genetic basis of pulmonary arterial hypertension.
Ma L et al.
Human Genetics, 2014
Genetics: Potassium channelopathy implicated in the pathogenesis of familial PAH.
Roberts A
Nature Reviews. Cardiology, 2013
A novel channelopathy in pulmonary arterial hypertension.
Ma L et al.
The New England Journal of Medicine, 2013
Select a paper to view details